Breakthroughs and challenges in the management of tropomyosin receptor kinase fusion-positive tumors

被引：0

作者：

Mamdani, Hirva ^{[1
]}

Jalal, Shadia I. ^{[2
]}

机构：

[1] Wayne State Univ, Karmanos Canc Inst, 4100 John R, Detroit, MI 48201 USA

[2] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA

来源：

ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷

关键词：

TRK; ENTRECTINIB; INHIBITOR; ONCOGENE; ROS1;

D O I：

10.21037/atm.2019.06.41

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[31] Activity of Larotrectinib in Tropomyosin Receptor Kinase Fusion Lung Cancer
Farago, A. F.
Kummar, S.
Moreno, V.
Patel, J.
Lassen, U.
Rosen, L.
Childs, B. H.
Hyman, D. M.
Drilon, A.
JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : S28 - S28
[32] Tropomyosin Receptor Kinase Inhibitors for the Treatment of TRK Fusion Cancer
Laetsch, Theodore W.
Hong, David S.
CLINICAL CANCER RESEARCH, 2021, 27 (18) : 4974 - 4982
[33] Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors
Prada, Elke Tatjana Aristizabal
Heinzle, Vera
Knoesel, Thomas
Noelting, Svenja
Spoettl, Gerald
Maurer, Julian
Spitzweg, Christine
Angele, Martin
Schmidt, Nina
Beuschlein, Felix
Stalla, Guenter K.
Blaser, Rainer
Kuhn, Klaus A.
Auernhammer, Christoph J.
ENDOCRINE-RELATED CANCER, 2018, 25 (05) : 547 - 560
[34] Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors
Naito, Yoichi
Mishima, Saori
Akagi, Kiwamu
Hayashi, Naomi
Hirasawa, Akira
Hishiki, Tomoro
Igarashi, Ataru
Ikeda, Masafumi
Kadowaki, Shigenori
Kajiyama, Hiroaki
Kato, Motohiro
Kenmotsu, Hirotsugu
Kodera, Yasuhiro
Komine, Keigo
Koyama, Takafumi
Maeda, Osamu
Miyachi, Mitsuru
Nishihara, Hiroshi
Nishiyama, Hiroyuki
Ohga, Shouichi
Okamoto, Wataru
Oki, Eiji
Ono, Shigeru
Sanada, Masashi
Sekine, Ikuo
Takano, Tadao
Tao, Kayoko
Terashima, Keita
Tsuchihara, Katsuya
Yatabe, Yasushi
Yoshino, Takayuki
Baba, Eishi
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (07) : 827 - 840
[35] Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors
Yoichi Naito
Saori Mishima
Kiwamu Akagi
Naomi Hayashi
Akira Hirasawa
Tomoro Hishiki
Ataru Igarashi
Masafumi Ikeda
Shigenori Kadowaki
Hiroaki Kajiyama
Motohiro Kato
Hirotsugu Kenmotsu
Yasuhiro Kodera
Keigo Komine
Takafumi Koyama
Osamu Maeda
Mitsuru Miyachi
Hiroshi Nishihara
Hiroyuki Nishiyama
Shouichi Ohga
Wataru Okamoto
Eiji Oki
Shigeru Ono
Masashi Sanada
Ikuo Sekine
Tadao Takano
Kayoko Tao
Keita Terashima
Katsuya Tsuchihara
Yasushi Yatabe
Takayuki Yoshino
Eishi Baba
International Journal of Clinical Oncology, 2023, 28 : 827 - 840
[36] Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology
Naito, Yoichi
Mishima, Saori
Akagi, Kiwamu
Igarashi, Ataru
Ikeda, Masafumi
Okano, Susumu
Kato, Shunsuke
Takano, Tadao
Tsuchihara, Katsuya
Terashima, Keita
Nishihara, Hiroshi
Nishiyama, Hiroyki
Hiyama, Eiso
Hirasawa, Akira
Hosoi, Hajime
Maeda, Osamu
Yatabe, Yasushi
Okamoto, Wataru
Ono, Shigeru
Kajiyama, Hiroaki
Nagashima, Fumio
Hatanaka, Yutaka
Miyachi, Mitsuru
Kodera, Yasuhiro
Yoshino, Takayuki
Taniguchi, Hiroya
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (03) : 403 - 417
[37] Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer
Wong, Derek
Yip, Stephen
Sorensen, Poul H.
PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (03) : 1385 - 1399
[38] Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology
Yoichi Naito
Saori Mishima
Kiwamu Akagi
Ataru Igarashi
Masafumi Ikeda
Susumu Okano
Shunsuke Kato
Tadao Takano
Katsuya Tsuchihara
Keita Terashima
Hiroshi Nishihara
Hiroyki Nishiyama
Eiso Hiyama
Akira Hirasawa
Hajime Hosoi
Osamu Maeda
Yasushi Yatabe
Wataru Okamoto
Shigeru Ono
Hiroaki Kajiyama
Fumio Nagashima
Yutaka Hatanaka
Mitsuru Miyachi
Yasuhiro Kodera
Takayuki Yoshino
Hiroya Taniguchi
International Journal of Clinical Oncology, 2020, 25 : 403 - 417
[39] Survival outcomes of patients with tropomyosin receptor kinase fusion-positive cancer receiving larotrectinib versus standard of care: a matching-adjusted indirect comparison using real-world data
Bokemeyer, C.
Abrams, K.
Garcia-Foncillas, J.
Italiano, A.
Lassen, U. N.
Linsell, L.
Marian, M.
Paracha, N.
Sullivan, S.
Thompson, J.
ANNALS OF ONCOLOGY, 2024, 35
[40] Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World Data
Bokemeyer, Carsten
Paracha, Noman
Lassen, Ulrik
Italiano, Antoine
Sullivan, Sean D.
Marian, Marisca
Brega, Nicoletta
Garcia-Foncillas, Jesus
JCO PRECISION ONCOLOGY, 2023, 7

← 1 2 3 4 5 →